Myomo, Inc.

Myomo, Inc. (MYO) filed Amendment No. 1 to its June 26, 2026 Form 8-K solely to correct exhibit labeling errors. Amendment No. 3 to the 2018 Stock Option and Incentive Plan, previously mislabeled as Exhibit 3.1, is now properly labeled as Exhibit 10.1, and the amendment to the Company's Eighth Amended and Restated Certificate of Incorporation, previously mislabeled as Exhibit 10.1, is now properly labeled as Exhibit 3.1. Appropriate hyperlinks in Item 9.01 were also added. No substantive changes were made to any disclosed matters from the June 25, 2026 Annual Meeting, which covered the equity plan share increase, charter amendment, and director elections.

Myomo, Inc. (MYO) reported results from its June 25, 2026 Annual Meeting of Stockholders, at which shareholders approved three significant measures. Stockholders approved an amendment to the 2018 Stock Option and Incentive Plan increasing available shares by 1,833,000, and approved a charter amendment increasing authorized common stock to 100,000,000 shares, with the charter amendment becoming effective upon same-day filing with the Delaware Secretary of State. The annual meeting also included director elections and other routine proposals. Myomo develops powered orthoses — motorized braces — for people with upper-limb paralysis resulting from stroke or incomplete spinal cord injury.